Delpuech, Oona
Douthwaite, Julie A.
Hill, Thomas
Niranjan, Dhevahi
Malintan, Nancy T.
Duvoisin, Hannah
Elliott, Jane
Goodfellow, Ian
Hosmillo, Myra
Orton, Alexandra L.
Taylor, Molly A.
Brankin, Christopher
Pitt, Haidee
Ross-Thriepland, Douglas
Siek, Magdalena
Cuthbert, Anna
Richards, Ian
Ferdinand, John R.
Barker, Colin
Shaw, Robert
Ariani, Cristina
Waddell, Ian
Rees, Steve
Green, Clive
Clark, Roger
Upadhyay, Abhishek
Howes, Rob
Funding for this research was provided by:
Wellcome Trust (097997/Z/11/Z and 207498/Z/17/Z, 097997/Z/11/Z and 207498/Z/17/Z)
Article History
Received: 29 July 2021
Accepted: 3 February 2022
First Online: 21 February 2022
Competing interests
: Colin Barker is Chief Scientific Officer for BiologIC Technologies. All other authors declare no competing interests relevant to the submitted work.